Type 1 Diabetes Mellitus: Clinical Trials

721 trials for Type 1 Diabetes Mellitus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

483 completed, 60 recruiting, 52 unknown, 44 terminated. 281 Not applicable, 129 Phase 2, 110 Phase 1, 66 Phase 3, 47 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable281Completed 196, Unknown 19, Not yet recruiting 18, Recruiting 18, Terminated 13, Active not recruiting 11, Withdrawn 5, Enrolling by invitation 1
Phase 2129Completed 71, Terminated 15, Recruiting 14, Active not recruiting 10, Unknown 8, Withdrawn 6, Not yet recruiting 5
Phase 1110Completed 74, Terminated 9, Unknown 9, Withdrawn 8, Recruiting 6, Active not recruiting 3, Not yet recruiting 1
Phase 366Completed 51, Terminated 6, Active not recruiting 4, Recruiting 4, Unknown 1
Phase 447Completed 35, Unknown 7, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Early Phase 111Completed 7, Recruiting 3, Unknown 1

Follow Type 1 Diabetes Mellitus: new trials by email Literature Review of Type 1 Diabetes Mellitus trials Research Report on Type 1 Diabetes Mellitus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
Recombinant Zoster Vaccine (Shingrix; RZV), Semaglutide (Ozempic®), Placebo (saline injection) - Type 1 Diabetes Mellitus
Phase 2Not yet recruitingMinistry of Health, Saudi Arabia2402027-01-012026-05-29
Sequential Immune Modulation and Antigen-Specific Tolerance Induction for Disease Modification in Recent-Onset Type 1 Diabetes
Teplizumab, Intralymphatic Insulin Immunotherapy (ILIT) - Type 1 Diabetes Mellitus (T1DM), Type 1 Diabetes Mellitus
Phase 1Not yet recruitingAbdullah Kars602027-01-012026-05-27
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
Tirzepatide - Type 1 Diabetes Mellitus, Overweight and Obesity
Phase 2Not yet recruitingRoyal North Shore Hospital402026-12-012025-07-29
A Phase 2 Two-Part Study of Oral PS1 in Healthy Volunteers and Adults With Newly Diagnosed Type 1 Diabetes
PS1, Placebo - Type 1 Diabetes Mellitus
Phase 2Not yet recruitingPharmasaga Co. Ltd.362026-11-212026-10-22
DiaBuddy: AI-Enabled Digital Self-Management for Youth With Type 1 Diabetes
DiaBuddy: AI-Enabled Digital Self-Management Intervention, Usual Diabetes Care - Type 1 Diabetes Mellitus, Diabetes Self-Management Education
Not applicableNot yet recruitingDr. Juwayria Omar1402026-10-022026-10-06
Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
Standard-of-Care Guidance (SoC), Usual Care (UC), netIOB & Exercise Toolkit (NEXT) - Type 1 Diabetes Mellitus, Exercise Physiology
Not applicableNot yet recruitingStanford University202026-10-012026-08-12
VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes
VV-14300, VV-14299 - Type 1 Diabetes Mellitus
Phase 1 / Phase 2RecruitingKriya Therapeutics, Inc.292026-10-012026-10-05
VV-14300 for the Treatment of Type 1 Diabetes
VV-14300 - Type 1 Diabetes Mellitus
Phase 1 / Phase 2RecruitingKriya Therapeutics, Inc.292026-10-012026-10-05
Gastrointestinal Symptoms in Children With Type 1 Diabetes
Type 1 Diabetes Mellitus
Not yet recruitingAssiut University2542026-09-262026-09-28
Exploring Skin Barrier Function, Recurrence of Diabetes Device-Related Contact Dermatitis, and Evaluation of Hydrocolloid and Silicone-Based Patches for Its Prevention in Children and Adolescents With Type 1 Diabetes
hydrocolloid patch as patch used in the Sandwich method, Silicone-based patch as patch used in the Sandwitch method - Contact Dermatitis, Type 1 Diabetes Mellitus
Not applicableRecruitingSteno Diabetes Center Copenhagen302026-09-042026-08-25
How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver
Imaging PET/MRI, Stable isotope infusions, meal test - Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH)
Not applicableNot yet recruitingUniversité de Sherbrooke322026-09-012025-08-21
Feasibility and Effectiveness of an AI-Powered Carbohydrate Counting Educational Platform to Support Parents of Children With Type 1 Diabetes
AI-Powered Carbohydrate Counting Educational Platform - Type 1 Diabetes Mellitus
Not applicableNot yet recruitingSultan Qaboos University802026-09-012026-06-30
Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.
Sotagliflozin initiation - Type 1 Diabetes Mellitus, Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM)
Phase 2Not yet recruitingHealthPartners Institute802026-09-012026-08-27
Omnipod 5 Implementation in Belgian Paediatric Diabetes Care
Tubeless Hybrid Closed-Loop Insulin Delivery System - Type 1 Diabetes Mellitus
Not yet recruitingQueen Fabiola Children's University Hospital2002026-09-012026-08-25
"Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds"
Sham ultrasound (placebo), Propolis gel (10%) - Diabetic Foot Ulcer t, Type 1 Diabetes Mellitus
Not applicableNot yet recruitingSinai University802026-08-302026-08-04
Oral Verapamil Among Newly Diagnosed Children and Adolescents With Type 1 Diabetes
Verapamil oral, Placebo - Type 1 Diabetes Mellitus
Phase 2 / Phase 3RecruitingAin Shams University702026-08-202026-09-04
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Cherry Sports Drink - Non-Nutritive Sweetener, Type 1 Diabetes
Not applicableRecruitingMedical College of Wisconsin202026-08-052026-10-20
Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection
CGM Devices - Type 1 Diabetes Mellitus
Not applicableNot yet recruitingSAVA Technologies Ltd.202026-08-012026-07-07
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Antithymocyte Globulin (ATG), Teplizumab - Type 1 Diabetes Mellitus
Phase 2RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)602026-07-292026-09-09
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Tirzepatide 2.5mg weekly, Placebo injection (normal saline) - Type 1 Diabetes Mellitus
Phase 2RecruitingVictor Chang Cardiac Research Institute442026-07-072026-09-16

Showing 20 of 721. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 1 (721)  ·  Diabetes Mellitus (85)  ·  Hypoglycemia (50)  ·  Diabetes Mellitus, Type 2 (45)  ·  Insulin Resistance (33)  ·  Motor Activity (29)  ·  Autoimmune Diseases (14)  ·  Hyperglycemia (13)  ·  Diabetic Nephropathies (7)  ·  Metabolic Diseases (7)  ·  Overweight (6)  ·  Diabetes Complications (5)  ·  Diabetic Ketoacidosis (5)  ·  Endocrine System Diseases (5)  ·  Glucose Metabolism Disorders (5)

Broader conditions

Nutritional and Metabolic Diseases (721)  ·  Immune System Diseases (718)  ·  Endocrine System Diseases (716)  ·  Glucose Metabolism Disorders (716)  ·  Metabolic Diseases (714)  ·  Autoimmune Diseases (707)  ·  Diabetes Mellitus (636)  ·  Behavior (39)  ·  Hyperinsulinism (33)  ·  Pathological Conditions, Signs and Symptoms (29)  ·  Urogenital Diseases (25)  ·  Female Urogenital Diseases and Pregnancy Complications (23)  ·  Male Urogenital Diseases (19)  ·  Female Urogenital Diseases (17)  ·  Pathologic Processes (16)

Interventions

Insulin Lispro (41)  ·  Insulin (30)  ·  Insulin Glargine (30)  ·  Insulin Aspart (27)  ·  Continuous Glucose Monitoring (11)  ·  Islets of Langerhans Transplantation (11)  ·  insulin degludec (11)  ·  Pancreas, Artificial (9)  ·  pramlintide (9)  ·  teplizumab (9)  ·  Glucagon (8)  ·  dapagliflozin (8)  ·  Antilymphocyte Serum (7)  ·  insulin glulisine (7)  ·  (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (6)

Sponsors

Sanofi (28)  ·  University of Virginia (27)  ·  Eli Lilly and Company (14)  ·  Medtronic MiniMed, Inc. (14)  ·  Sansum Diabetes Research Institute (12)  ·  University of Colorado, Denver (12)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (11)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (10)  ·  Adocia (9)  ·  AstraZeneca (9)  ·  Mannkind Corporation (8)  ·  Nemours Children's Clinic (8)  ·  Stanford University (8)  ·  Institut de Recherches Cliniques de Montreal (7)  ·  University of Ljubljana, Faculty of Medicine (7)

Countries

United States (346)  ·  Canada (63)  ·  Germany (58)  ·  United Kingdom (51)  ·  Spain (32)  ·  Italy (31)  ·  France (30)  ·  China (29)  ·  Israel (26)  ·  Sweden (26)  ·  Denmark (24)  ·  Poland (23)  ·  Netherlands (22)  ·  Austria (20)  ·  Turkey (Türkiye) (20)

Top investigators

Bruce Buckingham, MD (9)  ·  Sue Brown, MD (9)  ·  Eyal Dassau, PhD (7)  ·  Jordan E Pinsker, MD (6)  ·  Rodolfo Alejandro, MD (6)  ·  Grit Andersen, MD (5)  ·  Remi Rabasa-Lhoret (5)  ·  Steven J Russell, MD, PhD (5)  ·  Howard Zisser, MD (4)  ·  Rubina A Heptulla, MD (4)  ·  Bernhard J. Hering, M.D. (3)  ·  Boris Kovatchev, PhD (3)

Results publications

PMID 39735417, PMID 42459945, PMID 19005394, PMID 23801798, PMID 33481552, PMID 35403243, PMID 19064853, PMID 19636033, PMID 20150283, PMID 20448066, PMID 20536518, PMID 21030684, PMID 21500267, PMID 21947298, PMID 22077236, PMID 22688340, PMID 22729476, PMID 22990096, PMID 23027646, PMID 23212717, PMID 23265339, PMID 23438305, PMID 23474588, PMID 23520132, PMID 23761102, PMID 24170751, PMID 24264395, PMID 24309189, PMID 24459159, PMID 24722493, PMID 24836354, PMID 24934506, PMID 25043685, PMID 25204977, PMID 25218922, PMID 25562265, PMID 25584994, PMID 25923552, PMID 25980755, PMID 25984873, PMID 26068866, PMID 26192006, PMID 26341632, PMID 26559501, PMID 26584339, PMID 26641212, PMID 26718501, PMID 26861924, PMID 26864236, PMID 26895792

NIH funding

2015 (5), 2014 (3), 2017 (3), 2018 (3), R01DK085623 (3), U01DK061055 (3), UC4DK097835 (3), 2019 (2), UC4DK108483 (2), 1DP3DK094292-01 (1), 1DP3DK101055 (1), 1DP3DK113235-01 (1), 1UC4DK095300-01 (1), 1UC4DK100238-01 (1), 1UC4DK106955-01 (1)